期刊文献+

三种控制性超促排卵方案在高龄妇女体外受精-胚胎移植中的疗效分析 被引量:3

Effect of Three Controlled Ovarian Hyperstimulation Protocols in Advanced Women Undergoing in vitro Fertilization and Embryo Transfer
原文传递
导出
摘要 目的探讨3种不同助孕方案在≥40岁妇女体外受精-胚胎移植(IVF-ET)周期中的临床效果。方法回顾性分析2010年8月-2012年2月期间,于四川大学华西第二医院生殖中心行IVF-ET助孕、年龄≥40岁妇女共245个周期的临床资料,排除一侧卵巢缺如患者3例,余242个周期根据助孕方案不同分为3组:拮抗剂组(GnRH-A方案组)44个周期、长方案组109个周期及短方案组89个周期,比较3种方式助孕的临床效果。结果 3组均无早发黄体生成素峰;长方案组应用促性腺激素(Gn)的时间最长,应用Gn数量最多,获得最高的获卵数及获胚数(P<0.05);3组的受精率、优胚率、冷冻胚胎数、周期取消率、卵巢过度刺激综合征发生率、早期流产率均无统计学意义(P>0.05),短方案组的种植率及临床妊娠率最低(P<0.05)。结论 GnRH-a长方案在≥40岁妇女的IVF-ET周期中具有较好的临床结局,在≥40岁妇女IVF-ET周期中具有与长方案相似的结局,并且可以减少Gn使用量,提高卵泡及胚胎质量,短方案组对≥40岁妇女临床效果较差。 Objective To discuss the effect of three assisted reproductive protocols in patients at 40 years old or above undergoing in vitro fertilization and embryo transfer(IVF-ET) treatment.Methods The clinical data of 245 IVF cycles initiated in women 40 years old or above from August 2010 to February 2012 in the West China Second University Hospital were analyzed retrospectively.Three cycles keeping only one ovary were excluded and all the rest of 242 cycles were divided into 3 groups based on different assisted reproductive protocols: GnRH-A protocol group(44 cycles),GnRH-a long protocol group(109 cycles) and GnRH-a short protocol group(89 cycles).The clinical outcomes were compared between different protocols.Results None of the three groups had endogenous LH peak.GnRH-a long protocol group had the longest duration of gonadotrophin administration,used the most total dose of gonadotrophin,and obtained the highest number of eggs and embryos(P0.05).There was no significant difference among the three groups in the fertility rate,the high-quality embryo rate,frozen embryo number,cycle cancellation rate,OHSS incidence and abortion rate(P0.05).The GnRH-a short protocol group had the lowest implantation rate and clinic pregnancy rate(P0.05).Conclusions GnRH-a long protocol has better clinical outcomes in IVF-ET cycles for women over 40 years old.The GnRH-A protocol can obtain similar effect,and can reduce the gonadotrophin usage and improve the quality of eggs and embryos.The effect of GnRH-a short protocol is poorer for women more than 40 years old.
出处 《华西医学》 CAS 2012年第12期1855-1858,共4页 West China Medical Journal
关键词 体外受精-胚胎移植 控制性超促排卵 促性腺激素释放激素拮抗剂 促性腺激素释放激素激动剂 In vitro fertilization and embryo transfer Controlled ovarian hyperstimulation Gonadotropin-releasing hormone agonist Gonadotropin-releasing hormone antagonist
  • 相关文献

参考文献15

  • 1Tsafrir A, Simon A, Margalioth EJ, et al. What should be the first- line treatment for unexplained infertility in women over 40 years of age ovulation induction and IUI, or IVF[J]. Reproductive Bio Medicine Online, 2009, 19(Suppl 4): 47-56.
  • 2肖劲松,陈双陨,张春莲,常双.促性腺激素释放激素拮抗剂在体外受精-胚胎移植中有效性的系统性评价[J].中国循证医学杂志,2010,10(12):1432-1438. 被引量:9
  • 3肖劲松,陈双郧,张春莲,常双.GnRH-拮抗剂对体外受精-胚胎移植中低反应患者有效性的系统性评价[J].现代妇产科进展,2011,20(4):300-306. 被引量:4
  • 4Veek LL. The morphological assessment of human oocytes and early concpti. In: Keel BA, Webster BW editors.Hand-book of the Laboratory Diagnosis and Treatment of Infertility[C]. Boca Raton FL: CRC Press, 1990: 353-369.
  • 5何钻玉,李琳,陈晓莉,李予,张清学,杨冬梓.不同年龄段不孕患者控制性超排卵中卵巢低反应的预测[J].中国妇产科临床杂志,2011,12(6):410-413. 被引量:25
  • 6Serour G, Mansour R, Serour A, et al. Analysis of 2,386 consecutive cycles of in vitro fertilization or intracytoplasmic sperm injection using autologous oocytes in women aged 40 years and above[J]. Fertil Steril, 2010, 94(5): 1707-1712.
  • 7Klipstein S, Regan M, Ryley DA, et al. One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above[J]. Fertil Steril, 2005, 84(2): 435-445.
  • 8Ng EH, Ho PC. Ageing and ART: a waste of time and money?[J]. Best Pract Res Clin Obstet Gynaecol, 2007, 21 (1): 5-20.
  • 9Tsafrir A, Simon A, Revel A, et al. Retrospective analysis of 1217 IVF cycles in women aged 40 years and older[J]. Reproductive BioMedicine Online, 2007,14(3): 348-355.
  • 10Avrech OM, Orvieto R, Pinkas H, et al. Inclusion of standard and low-dose gonadotropin releasing hormone-analog (short protocol) in controlled ovarian hyperstimulation regimens in normogonadotropic patients aged 40-48 years who are undergoing in vitro fertilization[J]. Gynecol Endocrinol, 2004, 19(5): 247-252.

二级参考文献59

  • 1朱亮,邢福祺.GnRH_A用药方案及其在控制性超促排卵中的应用进展[J].国外医学(计划生育.生殖健康分册),2007,26(4):183-186. 被引量:3
  • 2Xavier P,Gamboa C,Calejo L.A randomised study of GnRH antagonist (cetrorelix) versus agonist (busereline) for controlled ovarian stimulation:effect on safety and efficacy.Eur J Obstet Gynecol Reprod Biol,2005,120(1):185-189.
  • 3Albano C,Felberbaum RE,Smitzl J,et al.Ovarian stimulation with HMG:results of a prospective randomized phase Ⅲ European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin.Hum Reprod,2000,15(3):2421-2425.
  • 4The North American Ganirelix Study Group:M Fluker,W Schoolcraft,R T Scott,et al.Efficacy and safety of ganirelix acetate versus leuprolide acetate in womenundergoing controlled ovarian hyperstimulation.Fertil Steril,2001,75(1):38-45.
  • 5Roulier R,Chabert-Orsini V,Sitri MC,et al.Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix,3mg)in patients undergoing assisted reproduction treatment.Repred Bioned Online,2003,7(2):185-189.
  • 6Ye H,Huang GN,Zeng PH,et al.IVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol:a prospective and randomized study.J Assist Reprod Genet,2009,26:105-111.
  • 7Juni P,Altman DG,Egger M.Assessing the quality of controlled clinical trials.BMJ,2001,323:42-46.
  • 8Stroup DF,Berlin JA,Morton SC,et al.Meta-analysis of observa-tional studies epidemiology:a proposal for reporting.JAMA,2000,283(15):2008-2012.
  • 9European and Middle East Orgalutran Study Group.Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation.Hum Reprod,2001,16(4):644-651.
  • 10Olivennes F,Belaisch-Allart J,Emperaire JC.Prospective,randomized controlled study of in vitro fertilization-embryo transfer witha single dose of a luteinizing hormone releasing hormone (LHRH) antagonist(cetrorelix) or a depot formula of anLH-RH agonist (triptorelin).Fertil Steril,2000,73(2):314-320.

共引文献40

同被引文献66

  • 1方丛,彭文林,张敏芳,李涛,苗本郁,周灿权,庄广伦.观察早期卵裂在行卵母细胞质内单精子注射周期中的应用[J].中华妇产科杂志,2006,41(3):203-204. 被引量:6
  • 2赵海波,何亚绒,李爱莉,任菊霞.卵泡液干细胞因子水平对卵母细胞发育、受精和卵裂影响的实验研究[J].中国计划生育学杂志,2006,14(8):475-476. 被引量:11
  • 3Ng EH,Lau E Y,Yeung W S,et al. Oocyte and embryo quality in patients with excessive ovarian response during in vitro fertilization treatment. J Assist Reprod Genet ,2003,20 : 186-191.
  • 4Ziebe S, Bangsboll S, Schmidt K L, et al. Embryo quality in natural versus stimulated IVF cycles. Hum Reprod ,2004,19 : 1457-1460.
  • 5Orvieto R ,Meltcer S, Liberty G, et al. A combined approach to pa- tients with repeated IVF failures. Fertil Steri1,2010,94 :2462-2464.
  • 6Spandofer SD, Soslow R, Clark R, et al. Histulogic characteristics of the endometrium predicts success when utilizing autologous endome- trial eoculture in patients with IVF failure. Assist Reprod Genet, 2006,23 : 185-189.
  • 7Tan XW,Ma SF,Yu JN ,et al. Effects of species and cellular activity of oviduetal epithelial cells on their dialogue with co-cultured mouse embryos. Cell Tissue Res ,2007,327:55-66.
  • 8Joo BS, Kim MK ,Na Y, et al. The mechanism of action of coeulture on embryo development in the mouse model: direct embryo to cell contact and the removal of deleterious components. Fertil Steril, 2001,75 : 193-199.
  • 9王益兵,朱广琴,宋宇轩.序贯共培养体系对小鼠体外受精胚胎发育效果的影响.安徽农业科.2007,35:5429-5431.
  • 10Susan JP, Peter RB, Martin H J, et al. Transient cooling to room tem- perature can cause irreversible disruption of the meiotic spindle in the human oocyte. Fertil Steril, 1990,54 : 102-108.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部